by Sunshine Biopharma | Apr 25, 2022 | News
Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that two of its newly designed...
by Sunshine Biopharma | Apr 5, 2022 | News
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of...
by Sunshine Biopharma | Mar 10, 2022 | News
For Immediate Release March 10, 2022 MONTREAL, Canada, March 10, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc.(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceuticalcompany focused on the research, development and...
by Sunshine Biopharma | Feb 25, 2022 | News
For Immediate Release February 25, 2022 Montreal, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (NASDAQ: “SBFM” andSBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on theresearch, development and commercialization of oncology and...
by Sunshine Biopharma | Feb 17, 2022 | News
MONTREAL, Canada, Feb. 17, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs,...